Accelerating Drug Discovery with New Approach Methods (NAMs)

New approach methods (NAMs) are revolutionizing preclinical drug development by providing faster, cost-effective, and biologically relevant models in lieu of animal studies. This webinar will feature industry leaders from Aracari Bio, iXCells Biotech, and Farcast Bio as they discuss how their cutting-edge human model systems are being applied to real-world drug discovery contexts.

Meet the speakers: 

Satish Sankaran, PhD

Chief Scientific Officer at Farcast Biosciences

Talk title: Multi-modal readouts from TruTumor reproduces in-vivo tumor complexity to accurately map response and resistance to therapy

Jorge Urresti, PhD

Associate Director of Stem Cell Differentiation at iXCells

Talk title: Using an ASO strategy to revert MECP2 downregulation in a RETT syndrome model

Christopher Hughes, PhD

Chief Scientific Officer at Aracari Biosciences

Talk title: The promise of vascularized micro-physiological systems for human disease modeling All registrants will receive a recording of the event and a certificate of attendance.

All attendees will receive a recording of the event and a certificate of attendance.